Suppr超能文献

在微量滴定板试验中使用人中性粒细胞评估血小板活化因子(PAF)拮抗剂。

Evaluation of PAF antagonists using human neutrophils in a microtiter plate assay.

作者信息

Dewald B, Baggiolini M

出版信息

Biochem Pharmacol. 1987 Aug 1;36(15):2505-10. doi: 10.1016/0006-2952(87)90523-5.

Abstract

This paper describes a testing model for the detection and evaluation of PAF antagonists, based on the inhibition of PAF-elicited elastase release by human neutrophils. Incubations are performed in microtiter plates in the presence of a specific fluorogenic elastase substrate allowing direct measurement of the exocytosis response by means of a 96-well fluorescence reader. Determinations of the IC50 values for five established PAF antagonists, Ro 19-3704, BN 52021, CV-3988, 48740 RP and kadsurenone, showed that the new model is comparable in sensitivity and discriminative capacity to other in vitro assays. From the effect of antagonists on the PAF concentration-response curve pA2 values could be calculated and information on the type of antagonism obtained. BN 52021 was found to behave as a competitive antagonist while Ro 19-3704 showed a more complex type of inhibition. As a one-plate system, the test is simple to handle and highly reproducible, and appears therefore particularly useful for large drug screening programs.

摘要

本文描述了一种基于抑制人中性粒细胞PAF诱导的弹性蛋白酶释放来检测和评估PAF拮抗剂的测试模型。在微量滴定板中进行孵育,同时存在一种特定的荧光弹性蛋白酶底物,可通过96孔荧光读数器直接测量胞吐反应。对五种已确立的PAF拮抗剂Ro 19 - 3704、BN 52021、CV - 3988、48740 RP和海风藤酮的IC50值测定表明,新模型在灵敏度和鉴别能力方面与其他体外试验相当。根据拮抗剂对PAF浓度 - 反应曲线的影响,可以计算出pA2值,并获得有关拮抗类型的信息。发现BN 52021表现为竞争性拮抗剂,而Ro 19 - 3704表现出更复杂的抑制类型。作为一种单板系统,该测试操作简单且具有高度可重复性,因此对于大型药物筛选项目显得特别有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验